Home » ICMR-NIHR Bhubaneswar to Host Regional ADOPT Sensitisation Meeting on Health Technology Assessment The ICMR–National Institute of Health Research (ICMR-NIHR), Bhubaneswar, will host the Regional ADOPT Sensitisation Meeting on Health Technology Assessment (HTA) for Eastern India on Oct 30, 2026, at…
Updated - October 29, 2026 01:22 pm IST The story so far: The Indian Patent Office has rejected a patent application filed by the U.S.-based Global Alliance for TB Drug Development (TB Alliance) for the combination of bedaquiline, pretomanid and linezolid, known as BPaL.
Dengue virus is especially pernicious compared with many other viruses, as secondary infections can actually be worse than the first one. Human challenge study reveals how preexisting immunity affects dengue Dengue virus is especially pernicious compared with many other viruses,…
Infecting people with a weak strain of dengue virus is helping researchers to unravel the disease’s bizarre effects on the immune system. This unusual quirk has complicated dengue vaccine development. Now, a human challenge trial that exposed 45 people to a…
Roughly half of the world’s population is now at risk of dengue, with an estimated 100–400 million infections occurring each year. The viral infection (also known as break-bone fever) is more common in tropical and subtropical areas of the world. Currently,…
KARACHI – Sindh capital is witnessing a sharp rise in flu patients as H1N1 circulates ahead of winter, with Civil Hospital reporting twice as many patients with flu symptoms. Doctors urge residents to watch for symptoms of this virus. Port city doctors…
Residents have demanded that the Corporation regularly check the vacant plots and take steps to drain out the stagnant water; civic body issues notices to plot owners You are logged in You don’t have any Active Subscription. Subscribed with another…
Mumbai, October 27, 2026: In a significant step towards making treatment more affordable for patients with drug-resistant tuberculosis (MDR-TB), the Indian Patent Office has rejected a patent application filed by the Global Alliance for TB Drug Development (TB Alliance). The office upheld…
Updated - October 28, 2026 06:53 pm IST - New Delhi The Indian Patent Office has rejected a patent application filed by the U.S.-based Global Alliance for TB Drug Development (TB Alliance) for the combination of bedaquiline, pretomanid, and linezolid (BPaL), a six-month, all-oral treatment…
The Indian Patent Office has rejected a patent application by the US-based Global Alliance for TB Drug Development (TB Alliance) for BPaL, a treatment for drug-resistant tuberculosis (TB). The order, dated October 27, came after two objections were filed by patient…
Public health in India: ICMR research, TB elimination, dengue, malaria and swine flu, state health alerts and the air people breathe.
An article joins this feed when it matches these terms. Each one is also a search of its own.